CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in CollPlant Biotechnologies Ltd as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q1 2021
- Shares held
- 2.45M
- +633.3K (+34.9%) vs. Q1 2021
- Total value
- $51.9M
- +$27.5M (+112.9%) vs. Q1 2021
- New holders
- 6
- 2 more added
- Sold out
- 5
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $11.9M | 13.95% | +563,030 | New |
| Meitav Dash Investments Ltd | 547,730 | $11.6M | 0.30% | 00.0% | Unchanged |
| Investment Management of Virginia LLC | 530,104 | $11.2M | 2.16% | −296−0.1% | Reduced |
| Villere St Denis J & Co LLC | 247,250 | $5.24M | 0.28% | +5,000+2.1% | Added |
| Friess Associates LLC | 235,092 | $4.99M | 1.88% | −14,999−6.0% | Reduced |
| State Street Corp | 176,490 | $3.74M | 0.00% | +176,490 | New |
| Benjamin F. Edwards & Company, Inc. | 64,634 | $1.37M | 0.07% | −5,186−7.4% | Reduced |
| Weil Company, Inc. | 30,468 | $646.0K | 0.33% | −4,500−12.9% | Reduced |
| Raymond James & Associates | 20,800 | $441.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,034 | $276.0K | 0.00% | +13,034 | New |
| ACT Capital Management, LLC | 7,500 | $160.0K | 0.08% | +7,500 | New |
| Parallel Advisors, LLC | 4,299 | $91.0K | 0.00% | −823−16.1% | Reduced |
| FNY Investment Advisers, LLC | 4,000 | $84.0K | 0.03% | −6,000−60.0% | Reduced |
| UBS Group AG | 2,010 | $43.0K | 0.00% | +832+70.6% | Added |
| Tower Research Capital LLC (TRC) | 597 | $13.0K | 0.00% | +597 | New |
| Morgan Stanley | 150 | $3.00K | 0.00% | +150 | New |
| Brown Advisory Inc | 0 | $0 | 0.00% | −54,650−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −19,700−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −17,045−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −117−100.0% | Sold out |